136 related articles for article (PubMed ID: 33021411)
1. Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma.
Almasmoum HA; Airhihen B; Seedhouse C; Winkler GS
Leuk Lymphoma; 2021 Feb; 62(2):281-290. PubMed ID: 33021411
[TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
3. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
4. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
Maryati M; Airhihen B; Winkler GS
Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
[TBL] [Abstract][Full Text] [Related]
5. CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex.
Stoney PN; Yanagiya A; Nishijima S; Yamamoto T
J Mol Biol; 2022 May; 434(9):167523. PubMed ID: 35248544
[TBL] [Abstract][Full Text] [Related]
6. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.
Rouault JP; Prévôt D; Berthet C; Birot AM; Billaud M; Magaud JP; Corbo L
J Biol Chem; 1998 Aug; 273(35):22563-9. PubMed ID: 9712883
[TBL] [Abstract][Full Text] [Related]
7. The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation.
Aslam A; Mittal S; Koch F; Andrau JC; Winkler GS
Mol Biol Cell; 2009 Sep; 20(17):3840-50. PubMed ID: 19605561
[TBL] [Abstract][Full Text] [Related]
8. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.
Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L
J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressors BTG1 and BTG2: Beyond growth control.
Yuniati L; Scheijen B; van der Meer LT; van Leeuwen FN
J Cell Physiol; 2019 May; 234(5):5379-5389. PubMed ID: 30350856
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of anti-proliferative protein BTG1 and BTG2.
Kim SH; Jung IR; Hwang SS
BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434
[TBL] [Abstract][Full Text] [Related]
11. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.
Hata K; Nishijima K; Mizuguchi J
Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295
[TBL] [Abstract][Full Text] [Related]
12. The BTG2 protein is a general activator of mRNA deadenylation.
Mauxion F; Faux C; Séraphin B
EMBO J; 2008 Apr; 27(7):1039-48. PubMed ID: 18337750
[TBL] [Abstract][Full Text] [Related]
13. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton.
Tijchon E; van Ingen Schenau D; van Opzeeland F; Tirone F; Hoogerbrugge PM; Van Leeuwen FN; Scheijen B
PLoS One; 2015; 10(7):e0131481. PubMed ID: 26218146
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity.
Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z
Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182
[TBL] [Abstract][Full Text] [Related]
15. Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking.
Ameerul A; Almasmoum H; Pavanello L; Dominguez C; Winkler GS
J Mol Biol; 2022 Jul; 434(14):167662. PubMed ID: 35640718
[TBL] [Abstract][Full Text] [Related]
16. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
Stupfler B; Birck C; Séraphin B; Mauxion F
Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148
[TBL] [Abstract][Full Text] [Related]
17. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
[TBL] [Abstract][Full Text] [Related]
18. Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex in mRNA regulation and cell viability.
Mostafa D; Takahashi A; Yanagiya A; Yamaguchi T; Abe T; Kureha T; Kuba K; Kanegae Y; Furuta Y; Yamamoto T; Suzuki T
RNA Biol; 2020 Mar; 17(3):403-416. PubMed ID: 31924127
[TBL] [Abstract][Full Text] [Related]
19. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation.
Prévôt D; Voeltzel T; Birot AM; Morel AP; Rostan MC; Magaud JP; Corbo L
J Biol Chem; 2000 Jan; 275(1):147-53. PubMed ID: 10617598
[TBL] [Abstract][Full Text] [Related]
20. Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest.
Velayutham N; Calderon MU; Alfieri CM; Padula SL; van Leeuwen FN; Scheijen B; Yutzey KE
J Mol Cell Cardiol; 2023 Jun; 179():30-41. PubMed ID: 37062247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
